Sinocare (SZSE:300298) ROCE % : 6.90% (As of Sep. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Sinocare ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sinocare's annualized ROCE % for the quarter that ended in Sep. 2024 was 6.90%.

Sinocare ROCE % Historical Data

The historical data trend for Sinocare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocare ROCE % Chart

Sinocare Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

11.00

8.35

4.87

13.98

6.86

Sinocare Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															14.37	-5.81	10.50	14.03	6.90

Sinocare ROCE % Calculation

Sinocare's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	314.846	/	( ( (6195.493 - 1640.026)	+	(5926.972 - 1299.124) )	/ 2 )
	=	314.846	/	( (4555.467	+	4627.848)	/ 2 )
	=	314.846	/	4591.6575
	=	6.86 %

Sinocare's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	301.396	/	( ( (5876.338 - 1511.433)	+	(5933.439 - 1561.09) )	/ 2 )
	=	301.396	/	( ( 4364.905	+	4372.349 )	/ 2 )
	=	301.396	/	4368.627
	=	6.90 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Sinocare (SZSE:300298) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sinocare ROCE % Related Terms

Thank you for viewing the detailed overview of Sinocare's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinocare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sinocare Inc (SZSE:300298) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.265 Guyuan Road, Hi-tech Zone, Hunan Province, Changsha, CHN, 410205

Website

https://en.sinocare.com/

Sinocare Inc operates in the healthcare industry. It is engaged in the development, manufacturing, and marketing of diagnosis testing products for people with chronic diseases and healthcare professionals. Its product range covers household blood glucose meter, medical blood glucose meter, urinary microalbumin test strip and blood lipid uric acid products. In addition, the company also provides diabetes management information systems.

Executives

Li Xin Yi	Director
Li Shao Bo	Directors, executives
Che Hong Jing	Director
Wang Shi Min	Executives
Huang An Guo	Directors, executives
	Directors, executives
Pan Shu Guang	Securities Affairs Representative
Zhou Qing Hua	Supervisors
Ning Gui Chun	Supervisors
Wang Rui	Securities Affairs Representative
Chen Ji Dong	Supervisors
Che Hong Li	Directors, executives
Zhang Fan	Director

Sinocare Headlines

No Headlines